Abstract:Background:Although cigarette smoking is a risk factor for multiple disorders, it has long been thought to protect against Parkinson's disease (PD). Quantitative susceptibility mapping (QSM) is a novel magnetic resonance imaging (MRI)-based technique for assessing iron accumulation in vivo that has been widely applied in PD studies. This study aimed to investigate how cigarette smoking affects clinical performance of PD using quantified iron deposition as a proxy for PD pathology.Methods:In this observational study, we enrolled 35 male PD patients and 47 male healthy controls (HCs) and divided them into four groups. We performed an enhanced T2 star-weighted angiography (ESWAN) MRI sequence to measure the iron content of the nuclei within the nigrostriatal pathway. With the age and total intracranial volume (TIV) controlled as covariates, we performed inter-group comparisons of QSM values and moderation analyses for PD patients using smoking status and the smoking index (SI), respectively, as moderator variables.Results:The 2-way multivariate analysis of covariance (MANCOVA) results showed higher QSM values in the left red nucleus (P=0.024) in PD patients compared with those in HCs, and in the bilateral globi pallidi [left/right (L/R): P=0.009/0.003], substantia nigra pars compacta (SNc; L/R: P=0.001/0.037), and right substantia nigra pars reticulata (SNr; P=0.002) in non-smokers compared with smokers, with no marked interaction effect between PD and smoking status observed when applying the Bonferroni adjustment for multiple comparisons. Using cigarette smoking status and the SI as separate moderator variables, the moderation was shown up by a significant interaction effect in a disordinal and double-edged form. In our results, smoking-moderated protection for PD movement deficits emerged when PD was progressed. Among the affected deep brain nuclei, the nuclei most moderated by the impact of cigarette smoking on the interaction between brain iron and PD symptoms were the thalamus [smoking status associated with the Unified Parkinson's Disease Rating Scale (UPDRS) total score, P=0.04 (L); rigidity, P=0.03 (L); SI associated with UPDRS-III, P (L/R) =0.049/0.0497; rigidity, P (L/R) =0.01/0.02; bradykinesia, P (L/R) =0.048/0.04], the right red nucleus (SI associated with rigidity, P=0.04; bradykinesia, P=0.02), and the left SNc [smoking status associated with the Hoehn and Yahr (H&Y) stage, P=0.01].Conclusions:This was the first study investigating the impacts of current cigarette smoking on PD using quantified iron deposition. Our study confirmed the protective role of cigarette smoking against PD, consistent with the findings of previous studies. Furthermore, neuroprotection was present only when the PD pathology had progressed to a certain extent. In the interaction between iron deposition and clinical PD symptoms, our findings suggest that the thalamus, red nucleus, and SNc are likely to be the most affected nuclei moderated by cigarette smoking.

Pesticides and lifestyle factors are associated with disease severity of Parkinson's disease: a longitudinal study

Proximity to residential and workplace pesticides application and the risk of progression of Parkinson's diseases in Central California

Gene-Environment Interactions for Parkinson's Disease

Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 Variants

Exploring Environmental Modifiers of LRRK2-Associated Parkinson’s Disease Penetrance through Exposomics and Metagenomics of Household Dust

Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease

Epidemiology and etiology of Parkinson’s disease: a review of the evidence

The Protective Role of Cigarette Smoking Against Parkinson’s Disease Via Moderation of the Interaction Between Iron Deposition in the Nigrostriatal Pathway and Clinical Symptoms

Risk and protective factors in Parkinson's disease: a simultaneous and prospective study with classical statistical and novel machine learning models

Integration of Risk Factors for Parkinson Disease in 2 Large Longitudinal Cohorts

Lysosomal genes contribute to Parkinson’s disease near agriculture with high intensity pesticide use

Pesticides and the Gut Microbiota: Implications for Parkinson's Disease

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review

Association between cigarette smoking and Parkinson's disease: a neuroimaging study

Air Pollution and Parkinson Disease in a Population-Based Study

Analysis of serum levels of organochlorine pesticides and related factors in Parkinson's disease

Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications

More Research Is Needed on Lifestyle Behaviors That Influence Progression of Parkinson's Disease

Risk factors of Parkinson's disease: Simultaneous assessment, interactions and etiological subtypes.

Neural Substrates for the Association Between Cigarette Smoking and Parkinson's Disease

Association of Coffee Consumption and Striatal Dopamine Transporter Binding in Patients with Parkinson’s Disease and Healthy Controls